FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for Ranolazine (ANDA 211707), approving a generic Ranolazine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)